Vaxxinity Inc. Class A (VAXX) Financials

$0.00

$-0.09 (-99.89%)

As on 02-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	0.00	0.07	0.56	--
Cost of Revenue	2.09	2.23	1.68	1.94	0.05	0.11
Gross Profit	-2.09	-2.23	-1.68	-1.87	0.51	-0.11
Operating Expenses	50.26	56.05	74.30	123.20	32.79	13.66
Operating Profit (EBIT)	-51.17	-58.29	-75.98	-125.08	-32.28	-13.66
Other Income	0.42	--	0.95	-12.10	--	--
Profit before Tax	-49.91	-0.06	-75.22	-137.18	-39.96	-14.16
Provision for Tax	1.15	-0.06	-0.01	0.84	-4.58	0.06
Profit after Tax (Net Income)	-49.91	-0.06	-75.21	-137.18	-39.96	-14.22
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-13.98	--	-75.22	-137.18	-39.96	-14.22

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	13.41	13.41	62.18	128.62	-87.38	-48.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.30	13.30	13.28	10.56	100.29	30.23
Current Liabilities	17.61	17.61	30.94	27.49	37.22	19.88
Total Liabilities	61.92	44.31	106.40	166.67	50.14	1.60

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	11.08	11.08	12.51	12.54	14.47	0.16
Current Assets	33.23	33.23	93.89	154.13	35.67	1.44
Total Assets	77.54	44.31	106.40	166.67	50.14	1.60
Total Debt*	15.17	15.17	14.55	10.70	38.31	14.33
Net Current Assets	--	15.63	62.95	126.64	-1.55	-18.44

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-57.24	-55.93	-80.99	-33.91	-12.27
Cash Flow from Investing Activities	--	28.84	-54.39	-1.32	-1.48	-1.48
Cash from Financing Activities	--	-1.14	-0.17	196.17	66.11	11.14
Net Cash Inflow / Outflow	--	--	-110.49	-16.20	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.39	0.00	-0.60	-1.09	-0.32	--
Cash EPS ($)	--	0.02	-0.58	-1.09	-0.31	--
Adjusted Book Value ($)	--	0.11	0.49	1.03	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.45	-0.44	-0.65	-0.27	--
Free Cash Flow per Share ($)	--	-0.46	-0.46	-0.66	-0.28	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-0.11	-69.62	-304.00	96.00	--
ROE (%)	-268.93	-0.15	-78.84	-665.19	58.81	--
ROA (%)	-52.66	-0.08	-55.08	-126.54	-154.46	--
EBIT Margin (%)	--	--	7,470,800.00	-206,568.18	-6,961.40	--
Net Margin (%)	-11,939.23	--	-7,891.92	1,139.90	-7,173.61	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	1.00	-1.02	-0.88	--	--
EBIT Growth (%)	33.68	24.72	45.20	-251.61	-183.28	--
Net Profit Growth (%)	33.83	99.92	45.17	-243.31	-181.01	--
EPS Growth (%)	34.28	1.00	0.45	-2.42	--	--
Book Value Growth (%)	-71.20	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-1,899.31	-2.35	-5.13	--	--
Price / Book Value	0.01	8.06	2.84	5.47	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.98	-1.72	-1.43	-4.20	--	--
Close Price ($)	0.72	0.85	1.40	5.61	--	--
High Price ($)	3.10	4.47	10.57	22.77	--	--
Low Price ($)	0.56	0.69	1.24	5.26	--	--
Market Cap ($ Cr)	0.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	1.13	0.23	0.08	-0.44	-0.30
Short term debt to equity ratio	0.14	0.14	0.02	0.00	-0.32	-0.27
Current Ratio	1.89	1.89	3.03	5.61	0.96	0.07
Quick Ratio	1.89	--	2.84	5.30	0.87	--
Interest Coverage	-71.75	-80.80	-145.35	-162.30	-32.83	-31.47

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	-41,400.00	595.45	69.48	--
Asset Turnover	--	--	0.00	0.00	0.02	--
Receivable days	--	--	-147,378.38	2,158.30	226.23	--
Inventory Days	--	1,001.25	1,587.02	1,114.61	23,263.62	--
Payable days	--	578.61	920.39	1,151.47	36,191.36	4,383.00
Cash Conversion Cycle	--	--	-146,711.75	2,121.43	-12,701.51	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.